Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes
US6500931B1 · kind B1 · utility
11Cited by
6References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 1995 |
| Grant date | Dec 31, 2002 |
| Priority date | — |
| Expiry date | May 4, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/468
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Humanized antibodies are described which are specific to an Fc receptor (FcR). The humanized antibodies have at least a portion of a complementarity determining region (CDR) derived from a non-human antibody, e.g., murine, with the remaining portions being human in origin. The humanized antibodies can be used therapeutically as is or formulated as bifunctional molecules or immunotoxins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.